Jai Sunder*, Satya K Balasundaram, Gaurav Sharma, Brahmadev Pattnaik
Division of Animal Science, ICAR- Central Island Agricultural Research Institute, Port Blair, A&N Islands 744 101, India.
*Correspondence | Jai Sunder, ICAR-Central Island Agricultural Research Institute, Port Blair, A & N Islands, India; Email: jaisunder@rediffmail.com
Abstract
Foot and mouth disease (FMD) was first reported from Andaman & Nicobar Islands in 2005 and for the first time serotype “O” was isolated as the causative agent. Since then not any case of FMD has been reported. For routine serosurveillance and monitoring blood samples are being collected and screened for protective antibody titter in the vaccinated animals and antibodies against non-structural proteins (NSPs) for the infected animals. In the present study, samples were collected from the South Andaman district for the period from 2011-2014. The samples were screened for protective antibody titre by indirect liquid phase blocked (LPB) ELISA and for anti NSP protein by DIVA-ELISA. The result of the DIVA-ELISA revealed the prevalence of 9.52%, 7.42% and 9.21% for the year 2011-12, 2012-13 and 2013-14, respectively. The trend of the DIVA positive samples indicated that the animals are still showing DIVA+ve, without showing any clinical symptoms or outbreak since the last outbreak reported in 2005. The result of the LPB-ELISA indicated that, since 2012 there was sharp increase in the trend of pre and post protective antibody titre in the pre and post vaccinated animals. The analysis of the protective antibody titre with respect to herd immunity indicated the protection level of 88% for serotype O, 86% for serotype A and 93 % for serotype Asia –1, respectively. Based on the LPB-ELISA seroprevalence, it is concluded that the level of immunity for the serotype O, A and Asia –1 had increased manifold over the years, however the seroprevalence of NSP +ve cases was high without any infection or outbreak.
Keywords | A&N Islands, Foot and Mouth Disease, Sero-monitoring, DIVA, LPB-ELISA, Immunity



